SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Panacea Life Sciences Holdings, Inc. – ‘10-K’ for 12/31/23 – ‘EX-10.13’

On:  Monday, 4/1/24, at 6:09am ET   ·   For:  12/31/23   ·   Accession #:  1493152-24-12107   ·   File #:  1-38190

Previous ‘10-K’:  ‘10-K’ on 3/30/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   13 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/01/24  Panacea Life Sciences Holdin… Inc 10-K       12/31/23   69:26M                                    M2 Compliance LLC/FA

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.17M 
 2: EX-3.10     Articles of Incorporation/Organization or Bylaws    HTML     67K 
 3: EX-10.10    Material Contract                                   HTML     42K 
 4: EX-10.13    Material Contract                                   HTML     19K 
 5: EX-23.1     Consent of Expert or Counsel                        HTML     19K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     24K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
13: R1          Cover                                               HTML     86K 
14: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    141K 
15: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     60K 
                (Parenthetical)                                                  
16: R4          Condensed Consolidated Statements of Operations     HTML    108K 
                (Unaudited)                                                      
17: R5          Condensed Consolidated Statements of Stockholders'  HTML     67K 
                (Deficit) Equity (Unaudited)                                     
18: R6          Statements of Cash Flows                            HTML    115K 
19: R7          Nature of Organization                              HTML     27K 
20: R8          Summary of Significant Accounting Policies          HTML    118K 
21: R9          Property, Equipment, Net of Accumulated             HTML     40K 
                Depreciation                                                     
22: R10         Inventory                                           HTML     27K 
23: R11         Operating Lease Right-Of-Use Assets and Operating   HTML     43K 
                Lease Liabilities - Related Party                                
24: R12         Notes Payable                                       HTML     49K 
25: R13         Stockholders? Equity                                HTML     91K 
26: R14         Commitments and Contingencies                       HTML     45K 
27: R15         Related Party Transactions                          HTML     37K 
28: R16         Income Taxes                                        HTML     33K 
29: R17         Subsequent Events                                   HTML     25K 
30: R18         Summary of Significant Accounting Policies          HTML    164K 
                (Policies)                                                       
31: R19         Summary of Significant Accounting Policies          HTML     75K 
                (Tables)                                                         
32: R20         Property, Equipment, Net of Accumulated             HTML     39K 
                Depreciation (Tables)                                            
33: R21         Inventory (Tables)                                  HTML     27K 
34: R22         Operating Lease Right-Of-Use Assets and Operating   HTML     39K 
                Lease Liabilities - Related Party (Tables)                       
35: R23         Notes Payable (Tables)                              HTML     32K 
36: R24         Stockholders? Equity (Tables)                       HTML     64K 
37: R25         Related Party Transactions (Tables)                 HTML     32K 
38: R26         Income Taxes (Tables)                               HTML     27K 
39: R27         Nature of Organization (Details Narrative)          HTML     21K 
40: R28         Schedule of Fair Value Assets Measured on           HTML     35K 
                Recurring Basis (Details)                                        
41: R29         Schedule of Marketable Securities (Details)         HTML     24K 
42: R30         Schedule of Intangible Assets and Goodwill          HTML     35K 
                (Details)                                                        
43: R31         Schedule of Revenue From Contract With Customer     HTML     26K 
                (Details)                                                        
44: R32         Schedule of Anti-Dilutive Diluted Loss Per Share    HTML     48K 
                (Details)                                                        
45: R33         Summary of Significant Accounting Policies          HTML     51K 
                (Details Narrative)                                              
46: R34         Schedule of Property Plant and Equipment Useful     HTML     36K 
                Lives (Details)                                                  
47: R35         Schedule of Property and Equipment (Details)        HTML     39K 
48: R36         Property, Equipment, Net of Accumulated             HTML     22K 
                Depreciation (Details Narrative)                                 
49: R37         Schedule of Inventory (Details)                     HTML     30K 
50: R38         Schedule of Right of Use Asset and Liability        HTML     36K 
                (Details)                                                        
51: R39         Schedule of Maturity of Operating Lease             HTML     37K 
                Liabilities (Details)                                            
52: R40         Operating Lease Right-Of-Use Assets and Operating   HTML     28K 
                Lease Liabilities - Related Party (Details                       
                Narrative)                                                       
53: R41         Schedule of Notes Payable Related Party (Details)   HTML     27K 
54: R42         Schedule of Notes Payable (Details)                 HTML     26K 
55: R43         Notes Payable (Details Narrative)                   HTML     77K 
56: R44         Schedule of Stock Options (Details)                 HTML     57K 
57: R45         Schedule of Warrants Outstanding (Details)          HTML     52K 
58: R46         Summary of Restricted Stock (Details)               HTML     22K 
59: R47         Stockholders? Equity (Details Narrative)            HTML    126K 
60: R48         Commitments and Contingencies (Details Narrative)   HTML     61K 
61: R49         Schedule of Related Party Transactions Loans        HTML     34K 
                (Details)                                                        
62: R50         Schedule of Effective Tax Rate (Details)            HTML     31K 
63: R51         Income Taxes (Details Narrative)                    HTML     23K 
64: R52         Subsequent Events (Details Narrative)               HTML     33K 
66: XML         IDEA XML File -- Filing Summary                      XML    117K 
69: XML         XBRL Instance -- form10-k_htm                        XML   1.09M 
65: EXCEL       IDEA Workbook of Financial Report Info              XLSX    115K 
 9: EX-101.CAL  XBRL Calculations -- plsh-20231231_cal               XML    157K 
10: EX-101.DEF  XBRL Definitions -- plsh-20231231_def                XML    461K 
11: EX-101.LAB  XBRL Labels -- plsh-20231231_lab                     XML    940K 
12: EX-101.PRE  XBRL Presentations -- plsh-20231231_pre              XML    721K 
 8: EX-101.SCH  XBRL Schema -- plsh-20231231                         XSD    136K 
67: JSON        XBRL Instance as JSON Data -- MetaLinks              434±   616K 
68: ZIP         XBRL Zipped Folder -- 0001493152-24-012107-xbrl      Zip    280K 


‘EX-10.13’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 10.13

 

 

 
 

 

 

 

 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/06/24  Panacea Life Sciences Holdin… Inc 10-Q        3/31/24   60:4.6M                                   M2 Compliance LLC/FA


12 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/05/24  Panacea Life Sciences Holdin… Inc 8-K:1,9     1/29/24   13:23M                                    M2 Compliance LLC/FA
10/05/23  Panacea Life Sciences Holdin… Inc 8-K:1,2,3,510/05/23   18:869K                                   M2 Compliance LLC/FA
 7/10/23  Panacea Life Sciences Holdin… Inc 8-K:1,7,9   7/03/23   16:5.8M                                   M2 Compliance LLC/FA
 3/30/23  Panacea Life Sciences Holdin… Inc 10-K       12/31/22   69:5.5M                                   M2 Compliance LLC/FA
 4/29/22  Panacea Life Sciences Holdin… Inc 10-K/A     12/31/21   13:1.6M                                   M2 Compliance LLC/FA
 3/04/22  Panacea Life Sciences Holdin… Inc 8-K:1,2,3,9 3/03/22   14:1M                                     M2 Compliance LLC/FA
10/29/21  Panacea Life Sciences Holdin… Inc 8-K:5,9    10/25/21   12:2.1M                                   M2 Compliance LLC/FA
 8/23/21  Panacea Life Sciences Holdin… Inc 10-Q        6/30/21   67:8.2M                                   M2 Compliance LLC/FA
 7/07/21  Panacea Life Sciences Holdin… Inc 8-K:1,3,5,7 6/30/21    6:487K                                   Blueprint/FA
 2/18/21  Panacea Life Sciences Holdin… Inc 8-K:1,3,8,9 2/16/21    4:4.3M                                   Blueprint/FA
 3/04/16  Panacea Life Sciences Holdin… Inc 8-K:1,3,5,9 2/29/16    3:593K                                   SEC Connect
 2/17/16  Panacea Life Sciences Holdin… Inc 8-K/A:1,3,512/14/15    5:237K                                   SEC Connect
Top
Filing Submission 0001493152-24-012107   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 8:00:19.2pm ET